Takeda Pharmaceutical Co Ltd ADR (TAK)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $68.98B
Last updated: Nov 17, 2026 at 4:37 PM ET
Takeda Pharmaceutical Co Ltd ADR (TAK) Stock Chart
Takeda Pharmaceutical Co Ltd ADR (TAK) has a latest price of $21.64 on Nov 17, 2026, 1.0% below its 52-week high of $21.86. Its price rose 54.0% over the past 12 months. The month-end price fell 6.9% over the 10 years through Oct 2026, a compound annual decline of 0.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $29.50 in Jan 2018 and its lowest $12.94 in Jun 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TAK with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TAK.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 18.0%, and over 6 months it rose 30.5%. The month-end price rose 53.8% over the 3 years through Oct 2026, a compound annual rate of 15.4%.
| Period | Change |
|---|---|
| 1 month | +10.4% |
| 3 months | +18.0% |
| 6 months | +30.5% |
| 12 months | +54.0% |
| 12 months, with dividends | +56.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +53.8% | +15.4% |
| 5 years | +49.1% | +8.3% |
| 10 years | -6.9% | -0.7% |
Price by Year
Its best calendar year was 2017, when the price rose 36.9%, and its weakest was 2018, when it fell 40.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $20.91 | +34.1% |
| 2025 | $15.59 | +17.7% |
| 2024 | $13.24 | -7.2% |
| 2023 | $14.27 | -8.5% |
| 2022 | $15.60 | +14.5% |
| 2021 | $13.63 | -25.1% |
| 2020 | $18.20 | -7.8% |
| 2019 | $19.73 | +17.3% |
| 2018 | $16.82 | -40.9% |
| 2017 | $28.45 | +36.9% |
Trading Range
The price is 10.9% above its 50-day average of $19.53 and 21.8% above its 200-day average of $17.76.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $21.64 | |
| 52-week high | $21.86 | -1.0% |
| 52-week low | $13.48 | +60.6% |
| 50-day average | $19.53 | +10.9% |
| 200-day average | $17.76 | +21.8% |
Price Risk
Over 3 years, its largest fall from a peak was 19.9%.
| Measure | Value |
|---|---|
| 1-year beta | 0.04 |
| Largest fall, 1 year | -19.9% |
| Largest fall, 3 years | -19.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TAK
What is TAK's 1-year price change?
Takeda Pharmaceutical Co Ltd ADR's price rose 54.0% over the past 12 months. With dividends included, the 12-month total return was 56.2%.
What is TAK's 5-year price change?
Takeda Pharmaceutical Co Ltd ADR's month-end price rose 49.1% over the 5 years through Oct 2026, a compound annual rate of 8.3%. These figures leave out dividends.
What is TAK's 52-week high and low?
Takeda Pharmaceutical Co Ltd ADR's 52-week high is $21.86 and its 52-week low is $13.48. Its latest price of $21.64 on Nov 17, 2026 is 1.0% below the high.
What is TAK's beta?
Takeda Pharmaceutical Co Ltd ADR's 1-year beta against the S&P 500 is 0.04, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 19.9%.
Is the TAK chart free?
Yes. Advanced Charting for TAK is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TAK pages: Overview, Dividends, Charting, Financials, Statistics, Valuation, Competitors